Trial | NCT00792727  Report issue

Title

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    ketoprofen ...

  • Study Participants

    380
Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.
The objective of this study is to demonstrate the short-term multiple dose efficacy and safety of HKT-500 in subjects with pain caused by mild to moderate osteoarthritis of the knee. The goal of the study is to gather additional information about the analgesic efficacy and safety of repeated, 24-hour applications of 2 HKT-500 patches per knee for a total of 28 days in subjects with pain caused by mild to moderate osteoarthritis of the knee.
Study Started
Sep 30
2007
Primary Completion
Apr 30
2008
Study Completion
May 31
2008
Last Update
Jun 04
2015
Estimate

Drug ketoprofen Patch

2 topical patches applied once daily for 28 days

  • Other names: Ketoprofen topical patch

Other Placebo Patch

2 topical placebo patches applied once daily for 28 days

  • Other names: Sham Treatment

Ketoprofen Patch Experimental

Treatment with experimental drug

Placebo Patch Placebo Comparator

Treatment with placebo drug

Criteria 

Inclusion Criteria:

man or woman ≥45 years of age.
clinical diagnosis of unilateral or bilateral OA of the knee
taking an NSAID or acetaminophen on a regular basis and has a history of knee pain amelioration with NSAID or acetaminophen use.
mild to moderate OA of the knee at the screening visit
subject exhibits an arthritis "flare" in the target knee within 7 days day of withdrawing from a NSAID or acetaminophen.
subject understands that treatment will be administered on an inpatient basis.
subject is capable of understanding and complying with the protocol and has signed the informed consent document.

Exclusion Criteria:

subject is a woman of childbearing potential who has a positive urine pregnancy test, is lactating, or who is not surgically sterile
subject has symptoms that are attributable to primary inflammatory diseases of the joint
subject has unstable knees including a history of the knee catching or giving way or physical examination evidence of instability
subject has arthropathies that occur in conjunction with systemic diseases
subject has a chronic pain condition
subject is grossly obese
subject has a history of knee surgery within the past 12 months or arthroscopy within the past 6 months.
subject has a history of osteotomies.
subject is not willing to discontinue the use of NSAIDs, acetaminophen or other prohibited treatments
subject used opioids for OA pain within 1 month
No Results Posted